Rasmusson, et al. v. Smithkline Beecham Corporation

Rasmusson and Smithkline appealed from an interference proceeding before the BAPI regarding their anti-cancer and anti-hair-loss drug. Both parties prevail on their arguments -- Rasmusson argued Smithkline's claims were anticipated and Smithkline argued that Rasmusson's claims were not enabled.
Listen to the CAFC's published opinion. [MP3]